Entering text into the input field will update the search result below

BioTime (NYSEMKT:BTX): Q4 EPS of -$0.12. Revenue of $1.2M (-30% Y/Y). (PR)

Mar. 19, 2013 6:48 AM ETEterna Therapeutics Inc. (ERNA) StockLCTXBy: Gaurav Batavia, SA News Editor
BioTime (NYSEMKT:BTX): Q4 EPS of -$0.12. Revenue of $1.2M (-30% Y/Y). (PR)

Recommended For You

More Trending News

About ERNA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ERNA--
Eterna Therapeutics Inc.